Actively Recruiting
Combined Effects of Alternate Nostril Breathing and Aerobic Interval Training on Blood Pressure and Heart Rate Products in Patients With Hypertension
Led by Foundation University Islamabad · Updated on 2025-09-17
36
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Hypertension is a major preventable risk factor for cardiovascular disease and mortality worldwide. This research aims to explore how combining aerobic interval training with alternate nostril breathing affects blood pressure, rate pressure product, and quality of life in adults with hypertension. The study is sponsored by Foundation University Islamabad and focuses on evaluating these combined lifestyle interventions in patients aged 25 to 50 years with stage 1 or stage 2 hypertension. Participants will be randomly assigned to one of two groups. One group will perform aerobic interval training alone using stationary cycling for 30-40 minutes three times a week over five weeks, with sessions supervised by a physiotherapist. The other group will combine the same aerobic training with alternate nostril breathing exercises immediately afterward, progressing from 5 minutes in the first week to 10 minutes in later weeks. Exercise intensity is tailored using heart rate reserve calculations, and each session includes warm-up and cool-down periods. Throughout the five-week intervention, outcome measures including heart rate, blood pressure, and rate pressure product will be recorded at the start and end of the study. All exercise sessions are supervised to ensure safety and adherence. This trial assesses how these interventions impact cardiovascular health markers and quality of life, with participation lasting the full five weeks of supervised training and assessment.
CONDITIONS
Brief Title
Combined Effects of Alternate Nostril Breathing and Aerobic Interval Training on Blood Pressure and Heart Rate Products in Patients With Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 25 to 50 years, male and female
- Diagnosed with stage 1 hypertension (130-139/80-89 mmHg) or stage 2 hypertension (≥140/90 mmHg) according to AHA/ACC 2017 Guidelines
- Able to understand and follow exercise instructions
You will not qualify if you...
- Diagnosed with any current infections
- Musculoskeletal or neurological conditions that prevent participation in physical activity
- Active smokers
- Any contraindications to exercise testing or training
- Pregnant females
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 5 weeks
Participants perform aerobic interval training three times a week for 5 weeks under the supervision of a physiotherapist. One group also practices alternate nostril breathing following each aerobic session.
3 supervised sessions per week
Trial Site Locations
Total: 1 location
1
Foundation University College of Physical Therapy, Islamabad, 44000
Rawalpindi, Pakistan, 46000
Actively Recruiting
Research Team
S
Sameen Fatima, DPT
Z
Zara Khalid, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here